Literature DB >> 17050633

Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis.

Wim Van Biesen1, Francis Verbeke, Francio Verbeke, Raymond Vanholder.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17050633     DOI： 10.1093/ndt/gfl601

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  14 in total

1.  Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.

Authors:  Ivana Mikolasevic; Sandra Milic; Sanjin Racki; Luka Zaputovic; Davor Stimac; Mladen Radic; Dean Markic; Lidija Orlic
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

2.  Associations between serum hepcidin level, FGF-21 level and oxidative stress with arterial stiffness in CAPD patients.

Authors:  Sena Memnune Ulu; Seref Yuksel; Atila Altuntaş; Emre Kacar; Ahmet Ahsen; Abdullah Altug; Sefa Celik; M Tugrul Sezer
Journal:  Int Urol Nephrol       Date:  2014-06-08       Impact factor: 2.370

3.  Identification of cardiovascular abnormalities by multiparametric magnetic resonance imaging in end-stage renal disease patients with preserved left ventricular ejection fraction.

Authors:  Ling Lin; Qiuxia Xie; Mei Zheng; Xuhui Zhou; Ilona A Dekkers; Qian Tao; Hildo J Lamb
Journal:  Eur Radiol       Date:  2021-02-24       Impact factor: 5.315

4.  Impact of dialysis modality on the survival of patients with end-stage renal disease and prior stroke.

Authors:  I-Kuan Wang; Wen-Miin Liang; Cheng-Li Lin; Yao-Lung Liu; Chiz-Tzung Chang; Tzung-Hai Yen; Chiu-Ching Huang; Fung-Chang Sung
Journal:  Int Urol Nephrol       Date:  2015-11-11       Impact factor: 2.370

5.  How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center.

Authors:  Gianluigi Zaza; Carlo Rugiu; Alessandra Trubian; Simona Granata; Albino Poli; Antonio Lupo
Journal:  BMC Nephrol       Date:  2015-04-14       Impact factor: 2.388

6.  Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients.

Authors:  Gianluigi Zaza; Simona Granata; Valentina Masola; Carlo Rugiu; Francesco Fantin; Loreto Gesualdo; Francesco Paolo Schena; Antonio Lupo
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

7.  Transcriptome analysis in patients with chronic kidney disease on hemodialysis disclosing a key role for CD16+CX3CR1+ monocytes.

Authors:  Eva Schepers; Erica Houthuys; Annemieke Dhondt; Grim De Meyer; Nathalie Neirynck; Pascale Bernaert; Rafael Van den Bergh; Peter Brouckaert; Raymond Vanholder; Griet Glorieux
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

8.  Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients--an observational study.

Authors:  Robert G Fassett; Ritza Driver; Helen Healy; Dwarakanathan Ranganathan; Sharad Ratanjee; Iain K Robertson; Dominic P Geraghty; James E Sharman; Jeff S Coombes
Journal:  BMC Nephrol       Date:  2009-03-12       Impact factor: 2.388

9.  Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome.

Authors:  Senija Rašić; Damir Rebić; Sabaheta Hasić; Ismar Rašić; Marina Delić Šarac
Journal:  Mediators Inflamm       Date:  2015-10-11       Impact factor: 4.711

10.  Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients.

Authors:  Ksenija Stach; Susanne Karb; Ibrahim Akin; Martin Borggrefe; Bernhard Krämer; Thorsten Kälsch; Anna-Isabelle Kälsch
Journal:  Mediators Inflamm       Date:  2017-07-09       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.